Advanced Search

Journal of Traditional Chinese Medicine >

2022 , Vol. 42 >Issue 2: 159 - 166

DOI: https://doi.org/10.19852/j.cnki.jtcm.2022.02.001

Meta-analysis

Acupoint application therapies for essential hypertension: a systematic review and Meta-analysis

  • Wei LIU ,
  • Xingjiang XIONG ,
  • Lumin QIAO ,
  • Yuyi CHEN ,
  • Yixuan LI ,
  • Xing SU ,
  • Fuyong CHU ,
  • Hongxu LIU
Expand
  • 1 Department of Cardiology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China
    2 Department of Cardiology, Guang′anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
    3 Department of Emergency, Yinchuan Chinese Medicine Hospital, Ningxia 750001, China
    4 Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China
    5 Community Healthcare Center of Shangzhuang Town, Beijing 100053,China
    6 Department of Medical Administration Division, Beijing Mentougou Hospital of Traditional Chinese Medicine, Beijing 102300, China
lhxcardiology1@163.com, Telephone: +8601052176633
Prof. CHU Fuyong and LIU Hongxu, Department of Cardiology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China. cfy0629@126.com;

Received date: 2021-01-27

  Accepted date: 2021-04-09

  Online published: 2022-04-01

Supported by

Beijing Natural Science Foundation (Molecular Mechanisms of Bushen Jiangya Decoction on Hypertensive Renal Damage Based on miR-21 Induced TGF β/Smad Signal Pathway)(7194277);Key Medical Professional Development Program Fund of Beijing Municipal Hospital Administration(ZYLX201817)

Fold

Abstract

OBJECTIVE: To evaluate the efficacy and safety of acupoint application therapies (AA) for hypertension.

METHODS: We searched PubMed, EMBASE, the Cochrane Center Controlled Trials Register, Chinese National Knowledge Infrastructure, Chinese Scientific Journal Database, and Wanfang Med Online Database from their inceptions to October 7, 2019. No language restriction was applied. We included randomized clinical trials testing AA against Western Medicine, AA versus placebo, AA combined with Western Medicine versus Western Medicine. Study selection, data extraction, quality assessment, and data analyses were conducted according to the Cochrane standards.

RESULTS: Totally 41 trials with 3772 participants were included. The methodological quality of the included trials was evaluated as generally low. AA plus Western Medicine significantly lowered systolic blood pressure (BP) [weighted mean difference (WMD): –10.36, 95% confidence intervals (CI): –12.62, –8.10; P < 0.000 01], diastolic BP (WMD: –5.71, 95% CI: –7.30, –4.13; P < 0.000 01), and total effect [risk ratio (RR): 1.23, 95% CI: 1.15, 1.32; P < 0.000 01]. The BP-lowering effect of AA was significantly higher than that of placebo [systolic BP (SBP): -8.05, 95% CI: –8.67, –7.43; P < 0.000 01; diastolic BP (DBP): –6.66, 95% CI: –7.31, –6.01, P < 0.000 01]. The total effect also improved significantly from baseline with AA than placebo (RR: 10.85, 95% CI: 4.71, 24.98; P < 0.000 01). Traditional Chinese Medicine symptoms score were significantly reduced by AA compared with Western Medicine (WMD: –1.75, 95% CI: –2.52, –0.99; P < 0.000 01), 10 trials reported adverse events, indicating that the safety of SSYX Capsule is still uncertain.

CONCLUSIONS: Application therapies may be considered a safe and beneficial for the treatment of hypertension and can reduce BP and improve the total effect. Further well-designed trials are needed to support our conclusions.

Key words： hypertension; systematic review; acupoint application

Cite this article

Wei LIU , Xingjiang XIONG , Lumin QIAO , Yuyi CHEN , Yixuan LI , Xing SU , Fuyong CHU , Hongxu LIU . Acupoint application therapies for essential hypertension: a systematic review and Meta-analysis[J]. Journal of Traditional Chinese Medicine, 2022 , 42(2) : 159 -166 . DOI: 10.19852/j.cnki.jtcm.2022.02.001

References

1. Wiysonge CS, Bradley HA, Volmink J. Beta-blockers for hypertension. Cochrane Database Syst Rev 2017; 20: CD002-3.
2. Bundy JD, He J. Hypertension and related cardiovascular disease burden in China. Ann Glob Health 2016; 82: 227-33.
3. Xiong XJ, Yang XC, Liu W, et al. Trends in the treatment of hypertension from the perspective of Traditional Chinese Med-icine. Evid Based Complementary Altern Med 2013; 2013: 1-8.
4. Wang J, Xiong XJ. Evidence-based Chinese medicine for hypertension. Evid Based Complementary Altern Med 2013; 978398: 1-2.
5. Xiong XJ, Che CT, Francesca B, et al. Evidence-based TAM classic herbal formula: from myth to science. Evid Based Complementary Altern Med 2017; 9493076: 1-3.
6. Kristoffersen AE, Sirois FM, Stub T, et al. Prevalence and predictors of complementary and alternative medicine use among people with coronary heart disease or at risk for this in the sixth Tromsø study: a comparative analysis using protection motivation theory. BMC Complement Altern Med 2017; 17: 324.
7. Yang XC, Xiong XJ, Yang GY, et al. Effectiveness of stimulation of acupoint KI 1 by artemisia vulgaris (Moxa) for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med 2014; 2014: 187484.
8. Moawia MA, Farah TS, Mai HS, et al. Evaluation of bloodletting cupping therapy in the management of hypertension. J Pharm Bioallied Sci 2018; 10: 1-6.
9. Lee SH, Chang GT, Zhang XY, et al. Acupoint herbal patching for asthma: a systematic review and Meta-analysis of randomized controlled trials. Medicine 2016; 95: 1-12.
10. Wang WH, Zhang LX, Li LF. Therapeutic effect of acupoint application with fructus evodiae rutaecarpae on patients with hyp-ertension. Shenzhen Zhong Xi Yi Jie He Za Zhi 2013; 23: 375-7.
11. Yin ZF, Wang SY. Preliminary clinical study on the treatment of refractory hypertension by acupuncture plus point application. Shanghai Zhen Jiu Za Zhi 2005; 24: 16-8.
12. Chen SY. The clinical observation and nursing care of acupoint application combined valsartan capsule for hypertension. Neimenggu Zhong Yi Yao Za Zhi 2013; 26: 147.
13. Zheng Y, Liu L, Le D. Clinical observation on the treatment of 40 cases of hypertension by Yongquan acupoint application combined medicine. Zhong Yi Wai Zhi Za Zhi 2014; 23: 42.
14. Liu JL, Zheng QL, Zhu W. Clinical observation of acupoint application combined valsartan capsule for hypertension. Hubei Zhony Yi Za Zhi 2012; 34: 65-66.
15. Lin JL, Gong JQ, Zhang XQ. Clinical observation on the treatment of 30 cases of hypertension with using Chinese combined western and medicine therapy. Jiangsu Zhong Yi Yao Za Zhi 2012; 44: 36-7.
16. Liu W, Feng Q, Li LT, et al. The clinical analysis of the treatment of 57 cases of hypertension by acupoint application. Guizhou Yi Yao 2012; 36: 1114-5.
17. Cui Y, Cui MY, Jin Y. Effect analysis of acupoint application of Chinese herbs in the treatment of hypertension. Zhong Guo Dang Dai Yi Yao 2013; 20: 107-8.
18. Zang DY, Wei ZX, Kong YL, et al. Clinical observation on the Traditional Chinese Medicine acupoint sticking therapy for the treatment of primary hypertension. Zhen Jiu Lin Chuang Za Zhi 2014: 30: 1-5.
19. Fu Y, Zhang XJ, Chen Y. Clinical observation on the acupoint sticking therapy for the treatment of hypertension. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi 2013; 11: 1521-1522.
20. Huang SX. Clinical observation on the combined with acupoint sticking therapy for the treatment of elderly isolated systolic hypertension. Guangxi Zhong Yi Yao Za Zhi 2012; 35: 23-24.
21. Luo FS, Li GH, Li QL, et al. Clinical observation on the acupoint application for elderly patients with hypertension. Zhong Wai Yi Liao 2011; 30: 149-150.
22. Zhang J, Li JF. Clinical observation on the treatment of 101 cases of primary hypertension in the community by acupoint application. Zhong Yi Wai Zhi Za Zhi 2010; 19: 22-23.
23. Yu HQ, Zhao QY. Clinical observation on the treatment of 120 cases of hypertension by acupoint application. Guang Ming Zhong Yi 2011; 26: 1184-1186.
24. Li CH, Teng J. Clinical curative effect analysis of acupoint application for elderly with hypertension. Shi Jie Zui Xin Yi Xue Xin Xi Wen Zhai 2015; 15: 137-138.
25. Jiao N. Clinical observation on treating primary hypertension with the acupoint sticker of the Sanzi Yangyin prescription. Zhong Yi Lin Chuang Yan Jiu 2015; 7: 6-8.
26. Zheng LW, Liu XZ, Yu XL. The influence of Tianma Gouteng Yin on blood pressure and syndrome in hyperactivity of liver-YANG syndrome of hypertensive patients. Fujian Zhong Yi Yao 2016; 47: 3-5.
27. Li XF, Yang BH, Wu YN, et al. Clinical observation on treating mild hypertension with the acupoint sticker of Tianma Gouteng Yin combined with levamlodipine besylate tablets. Neimenggu Zhong Yi Yao Za Zhi 2015; 4: 87-9.
28. Chen HY, Xie LZ. Clinical observation on treating hypertension with the acupoint sticker Yongquan point of Wuzhuyu powder mixed honey. J Bethune Med Sci 2015; 13: 647-648.
29. Xue H, Zhang YG. Curative effect observation of acupoint sticker Yongquan point for hypertension. Shi Jie Zui Xin Yi Xue Xin Xi Wen Zhai 2016; 16: 171-3.
30. Sun J, Yu L. Clinical observation on the treatment of 40 cases of hypertension by acupoint application on Yongquan point. Yunnan Zhong Yi Zhong Yao Za Zhi 2015; 36: 26-7.
31. Mei Y, Zheng R. The effect of acupoint paste on blood pressure in patients with hypertension. Neimenggu Zhong Yi Yao Za Zhi 2014; 1: 87-8.
32. Liu TT, Shen CZ. Effect of point application on quality of life of hypertension patients with phlegm dampness type. Hu Li Yan Jiu 2016; 30: 1216-8.
33. Wu JR. Efficacy observation on treating hypertension by plastering on acupoint combined with Shengtongping. Zhong Yi Lin Chuang Yan Jiu 2013; 5: 68-9.
34. Zhang Z, Chen M. Effect of antihypertensive drug combined with acupoint mounting on quality of life in elderly hypertension. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi 2011; 9: 531-2.
35. Liu JW. Clinical observation on the treatment of 50 cases of hypertension in by acupoint application combined with antihypertensive drugs. Guang Ming Zhong Yi 2015; 30: 807-9.
36. Zhao JL, Qiao JM. Effect of antihypertensive drug combined with acupoint on hypertension. Xin Zhong Yi 2016; 48: 5-6.
37. Cui SY, Sheng Y. Clinical observation on the acupoint plastering in the treatment of hypertension. Zhong Guo Zhong Yi Yao Xian Dai Yuan Cheng Jiao Yu 2016; 14: 104-5.
38. Wang LP. Observations on the therapeutic effect of acupoint application on senile hypertension of Yin Deficiency and Yang Excess. Shanghai Zhen Jiu Za Zhi 2015; 34: 421-422.
39. Ma SQ. Clinical observation on the treatment of 80 cases of hypertension of hyperaction of liver Yang by acupoint application on Yongquan point. Guang Ming Zhong Yi 2015; 30: 1028-9.
40. Chen LX. Clinical observation on treating hypertension with the acupoint sticker Yongquan point. Mod Diagn Treat 2016; 5: 836-7.
41. Huang LQ, He QX, Liu SY, et al. Clinical observation on the acupoint plastering in the treatment of hypertension of hyperaction of liver Yang. J Mod Med Health 2015; 31: 2504-5.
42. Qin CM, Yang YH, Huang CY, et al. To observe the curative effect of compound antihypertensive formula of acupoint application in the treatment of liver-yang hyperactivity type hypertension. Zhong Guo Ji Xu Yi Xue Jiao Yu 2017; 9: 186-8.
43. Yang YH, Qin CM, Huang CH. Efficacy of antihypertensive point acupoint in treating hypertension of liver-Yang hypertension. Zhong Guo Dang Dai Yi Yao 2018; 25: 114-6.
44. Li XM, Ye JF. Antihypertensive drugs combined with acupoint application in the treatment of patients with hypertension due to Yin deficiency and Yang hyperactivity. Jilin Zhong Yi Yao 2018; 38: 853-5.
45. Wang XZ. The clinical efficacy of acupoint sticking therapy of traditional Chinese medicine in the treatment of hypertension. Zhong Guo Ji Xu Yi Xue Jiao Yu 2018; 10: 141-143.
46. Xu JC. Therapeutic observation of acupoint sticking for hypertension due to hyperactivity of liver fire. Shanghai Zhen Jiu Za Zhi 2018; 37: 874-6.
47. Zhang YJ. Clinical observation on the acupoint plastering in the treatment of hypertension. Lin Chuang He Li Yong Yao 2015; 8: 122-3.
48. Cui YY. Efficacy observation on treating hypertension by plastering on acupoint. Shi Jie Zui Xin Yi Xue Xin Xi Wen Zhai 2016; 16: 37-38.
49. Niu LX. Clinical observation on the treatment of 50 cases of senile hypertension by acupoint application. Henan Zhong Yi 2014; 34: 344-345.
50. Liu XY, Nie R. Point application therapy treatment 60 cases of essential hypertension. Shi Yong Zhong Yi Nei Ke Za Zhi 2009; 23: 120-121.
51. Chen MY, Zhang CZ. The effects of acupoint application therapy on hypertension. Li Shi Zhen Guo Yi Guo Yao 2007; 18: 2788-2789.
52. Luo FS, Li GH, Li QL, et al. Clinical research on syndrome differentiation of point application in the treatment of primary hypertension. Zhong Guo Yi Yao Dao Bao 2011; 8: 108-110.
Options
Outlines

/

〈 〉